Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Epidemiology and Psychiatric Sciences|June 7, 2014
From stress to psychosis: whom, how, when and why?V MondelliClinical and Experimental Immunology|July 19, 2019
From early adversities to immune activation in psychiatric disorders: the role of the sympathetic nervous systemV Mondelli, A C VernonJournal of Endocrinological Investigation|March 15, 2005
The psychopharmacotherapy of anorexia nervosa: clinical, neuroendocrine and metabolic aspectsG Abbate Daga, L Gianotti, V Mondelli, et al.Psychological Medicine|October 8, 2013
Childhood stressors in the development of fatigue syndromes: a review of the past 20 years of researchA Borsini, N Hepgul, V Mondelli, et al.Molecular Psychiatry|June 3, 2015
Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-αD Baumeister, R Akhtar, S Ciufolini, et al.Psychological Medicine|September 16, 2015
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoidsE Appiah-Kusi, E Leyden, S Parmar, et al.Journal of Psychiatric Research|January 20, 2017
Do cognitive schema mediate the association between childhood trauma and being at ultra-high risk for psychosis?E Appiah-Kusi, H L Fisher, N Petros, et al.Translational Psychiatry|January 17, 2013
Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathwaysV Mondelli, C Anacker, A C Vernon, et al.Psychopharmacology|January 10, 2020
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosisE Appiah-Kusi, N Petros, R Wilson, et al.Translational Psychiatry|May 4, 2016
HPA-axis function and grey matter volume reductions: imaging the diathesis-stress model in individuals at ultra-high risk of psychosisI Valli, N A Crossley, F Day, et al.Pageof 3